CLINICAL RESEARCH

临床研究

• 批准号: 6563764
• 负责人: HYMAN MUSS
• 金额: $ 7.89万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-12-01 至 2002-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6563764
• 关键词: breast neoplasms; clinical research; cognitive behavior therapy; coping; female; female reproductive system neoplasm; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; prognosis; psychological aspect of cancer; raloxifene; social support network; tamoxifen; urinary tract neoplasms; women's health

The Clinical Research Program is dedicated to high quality clinical research directed at all aspects of cancer diagnosis, prognosis, treatment, and survivorship. The program lists 29 members with diverse expertise in all aspects of cancer care and research. Program progress and development sin the last 3 years are highlighted by recruitment of faculty with new research interested, targeted efforts to develop translational research activities in selected areas, and growth and enhancement of in- house and cooperative group clinical trials and outreach program./ A major focus of this program is on breast cancer, with recent growth of research activities in gynecologic and genitourinary cancer. Specific research studies in the program range from well-established behavioral research related to cancer diagnosis, to clinical interventions including in- house and cooperative group therapeutic trials, to development of a national surgical trial, to first-in-human studies including innovative developmental therapeutic research, to educational studies and programs related to physician, nursing and patient education. The Program Leader is Hyman Muss, M.D., Professor of Medicine and Associate Director for Clinical Research.

临床研究项目致力于针对癌症诊断、预后、治疗和生存各个方面的高质量临床研究。该计划列出了 29 名成员，他们在癌症护理和研究的各个方面拥有不同的专业知识。过去 3 年的项目进展和发展突出体现在招聘对新研究感兴趣的教师、有针对性地努力在选定领域开展转化研究活动以及内部和合作团体临床试验和外展项目的发展和加强。该计划的主要重点是乳腺癌，最近妇科和泌尿生殖系统癌症的研究活动有所增长。该计划的具体研究范围从与癌症诊断相关的成熟行为研究，到临床干预（包括内部和合作团体治疗试验），到国家外科试验的开发，到首次人体研究（包括创新的发育治疗）研究、教育研究以及与医生、护理和患者教育相关的项目。该项目负责人是医学博士、医学教授兼临床研究副主任 Hyman Muss。